Aduro BioTech Licenses GVAX Pancreas from BioSante Pharmaceuticals to Develop a Therapeutic Vaccine in Conjunction with CRS-207 for Pancreatic Cancer BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results